# Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters

> **NCT05365451** · EARLY_PHASE1 · COMPLETED · sponsor: **Washington State University** · enrollment: 16 (actual)

## Conditions studied

- Interaction
- Endogenous Biomarkers

## Interventions

- **DRUG:** MetFORMIN Oral Solution
- **DRUG:** Cimetidine 400 MG
- **DRUG:** Furosemide Oral Liquid Product
- **DRUG:** Probenecid 500 MG

## Key facts

- **NCT ID:** NCT05365451
- **Lead sponsor:** Washington State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-11
- **Primary completion:** 2023-07-22
- **Final completion:** 2023-07-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05365451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05365451, "Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05365451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*